论文部分内容阅读
目的：观察丹红注射液联合低分子肝素钠对急性脑梗临床疗效。方法应用丹红注射联合低分子肝素钠治疗急性脑梗塞68例，并设对照组68例进行分析。结果丹红注射液联合低分子肝素钠治疗急性脑梗死用药前后神经功能缺损评分及血小板、纤维蛋白原与对照组比较明显降低(<0.01)，治疗组凝血酶时间比对照组延长，治疗组总有效率92.6%，明显高于对照组的75.0%(<0.01)。结论丹红注射液联合低分子肝素钠治疗急性脑梗死疗效显著，安全性高，适合临床应用。“,”Objective To observe the Danhong injection combined low molecular heparin sodium on acute cerebral infarction clinical curative ef ect. Methods The application of combined low molecular heparin sodium Danhong injection treatment of 68 cases of acute cerebral infarction, and a control group of 68 cases were analyzed. Results Danhong injection combined low molecular heparin sodium neural function defect scale before and after drug treatment of acute cerebral infarction and platelets, fibrinogen significantly decreased compared with controls ( <0.01), the treatment group than the control group to extend the thrombin time, treatment group total ef ectiveness 92.6%, significantly higher than the 75.0%in the control group ( <0.01). Conclusion Dan red injection with low molecular heparin therapy of acute cerebral infarction curative ef ect is distinct, high security and suitable for clinical application.